LAURUSLABS
Laurus Labs
Each stock's 10,000-path forecast, rendered as light.
Laurus Labs (LAURUSLABS) Stock Analysis & Case Study
Is LAURUSLABS a good buy? The data-driven verdict.
Laurus Labs (LAURUSLABS) trades at ₹1,436,on the numbers it worth a closer look, a Downstox Snapshot Score of 56/100.
On the numbers, Laurus Labs (LAURUSLABS) worth a closer look, a Downstox Snapshot Score of 56/100, weighing expensive at 86.7× earnings, ROE of 18.3%, a 95% model probability of trading higher in a year. Below: the full bull case, bear case, sector-relative valuation, and a probability-weighted price target for 2027–2031.
Last updated . Data snapshot for research, not investment advice.
LAURUSLABS fundamentals at a glance, PE, PB, ROE, ROCE, market cap, dividend yield
Is LAURUSLABS overvalued? LAURUSLABS P/E vs its sector
LAURUSLABS's P/E of 86.7× sits above the sector peer median of 15.9×, so on earnings it screens richer than peers, while its 0.14% dividend yield is below the peer median of 1.65%.
LAURUSLABS share price target 2027, 2028, 2029, 2030, 2031, a probability view
Unlike a single guessed number, this is a probability-weighted range from a 10,000-path Monte-Carlo simulation on 2.0y of LAURUSLABS history (61%/yr drift, 33%/yr volatility).
| Year | Low (P10) | Median target (P50) | High (P90) | Upside vs today |
|---|---|---|---|---|
| LAURUSLABS 2027 | ₹1,607 | ₹2,441 | ₹3,747 | +73% |
| LAURUSLABS 2028 | ₹2,343 | ₹4,244 | ₹7,800 | +200% |
| LAURUSLABS 2029 | ₹3,542 | ₹7,373 | ₹15,601 | +422% |
| LAURUSLABS 2030 | ₹5,410 | ₹12,840 | ₹30,103 | +809% |
| LAURUSLABS 2031 | ₹8,563 | ₹22,251 | ₹58,451 | +1475% |
Median (P50) is the central estimate; the P10–P90 band is the 80% confidence range. Probabilities, not promises.
What is the probability LAURUSLABS goes up, or doubles?
The bull case for LAURUSLABS
- High return on equity (18.3%), the business compounds shareholder capital efficiently, the hallmark of a quality franchise.
- A 10,000-path probability model puts a 95% chance the price is higher in a year, with a median target of ₹2,441 (+73%).
- Upside scenario: the model's optimistic (P90) 3-year path reaches ₹15,601.
The bear case & risks
- A rich 86.7× P/E leaves a thin margin of safety if growth slows.
- A steep 14.6× price-to-book means most of the value is intangible/expectations, not assets on the books.
- Downside scenario: the model's pessimistic (P10) 3-year path falls to ₹3,542.
LAURUSLABS volatility & expected range, how bumpy is the ride?
Over the last 2.0 years LAURUSLABS compounded at 61%/year with annualized volatility of 33%. That volatility implies a 1-year 80% range of ₹1,607–₹3,747, the honest backbone behind any single price target.
LAURUSLABS price forecast, the full 60-month probability fan
LAURUSLABS price probability fan
Each band shows where 10,000 simulated paths land. The wider the fan, the more uncertainty.
Probability of key outcomes
What are the odds LAURUSLABS hits common targets within the simulated horizon?
Full multi-horizon detail on the LAURUSLABS price target & forecast page.
LAURUSLABS Piotroski F-Score: 4/9, how financially strong is it?
The Piotroski F-Score grades financial strength on nine profitability, leverage and efficiency checks. LAURUSLABS scores 4/9,mixed financial health.
LAURUSLABS MTF margin & leverage, Upstox, Zerodha, Groww, Dhan
Margin Trading Facility lets you buy LAURUSLABS with part of the capital. Lower margin % = higher leverage. Rates compared across brokers (no competitor publishes this):
| Broker | Margin required | Approx. leverage |
|---|---|---|
| Upstox | 30.4% | 3.3× |
| Zerodha | 25.9% | 3.9× |
| DhanCHEAPEST | 24.0% | 4.2× |
Compare every broker on the LAURUSLABS MTF page.
LAURUSLABS vs peers,sector comparison
About Laurus Labs: sector, index & market-cap context
Laurus Labs (LAURUSLABS) is a mid-cap NSE-listed company, and a constituent of the Nifty 100 index group, with a market capitalisation of ₹77,583 Cr. See more Nifty 100 stocks.
How the LAURUSLABS Snapshot Score & forecast are built
The Downstox Snapshot Score is a transparent, rules-based read of Laurus Labs's public fundamentals plus a statistical forecast, not an analyst opinion. It rewards low-to-fair valuation, high ROE/ROCE, a strong Piotroski F-Score, a dividend, low volatility and a favourable probability of upside; it penalises rich valuations, weak capital efficiency, a low F-Score and high volatility. The price target is a 10,000-path Monte-Carlo simulation on real historical volatility, a distribution, not a single guess. The bull and bear cases are generated from the same data, so you always see both sides.
This is information, not investment advice. Do your own due diligence and consult a SEBI-registered adviser before investing.
LAURUSLABS analysis, FAQs
Is Laurus Labs (LAURUSLABS) a good buy?
On the numbers, Laurus Labs (LAURUSLABS) worth a closer look, a Downstox Snapshot Score of 56/100, weighing expensive at 86.7× earnings, ROE of 18.3%, a 95% model probability of trading higher in a year. This is a data snapshot for research, not investment advice.
Is LAURUSLABS overvalued or undervalued?
LAURUSLABS trades at 86.7× earnings versus a peer median of 15.9×, so it screens richer than its sector peers.
What is the LAURUSLABS share price target for 2031?
LAURUSLABS's probability-weighted 2031 median target is ₹22,251, with an 80% range of ₹8,563–₹58,451 (10,000-path Monte-Carlo).
What is the probability LAURUSLABS doubles in 5 years?
The modelled probability of LAURUSLABS reaching ₹2,826 (2×) within 5 years is 100%.
What is the bull case for LAURUSLABS?
High return on equity (18.3%), the business compounds shareholder capital efficiently, the hallmark of a quality franchise. A 10,000-path probability model puts a 95% chance the price is higher in a year, with a median target of ₹2,441 (+73%).
What are the risks in LAURUSLABS?
A rich 86.7× P/E leaves a thin margin of safety if growth slows. A steep 14.6× price-to-book means most of the value is intangible/expectations, not assets on the books.